IL140938A0 - Molecules designated b7l-1 - Google Patents

Molecules designated b7l-1

Info

Publication number
IL140938A0
IL140938A0 IL14093899A IL14093899A IL140938A0 IL 140938 A0 IL140938 A0 IL 140938A0 IL 14093899 A IL14093899 A IL 14093899A IL 14093899 A IL14093899 A IL 14093899A IL 140938 A0 IL140938 A0 IL 140938A0
Authority
IL
Israel
Prior art keywords
molecules designated
molecules
designated
polypeptides
purified
Prior art date
Application number
IL14093899A
Other languages
English (en)
Original Assignee
Immunex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunex Corp filed Critical Immunex Corp
Publication of IL140938A0 publication Critical patent/IL140938A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70532—B7 molecules, e.g. CD80, CD86
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/027—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a retrovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL14093899A 1998-08-07 1999-08-05 Molecules designated b7l-1 IL140938A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9566398P 1998-08-07 1998-08-07
PCT/US1999/017906 WO2000008057A2 (fr) 1998-08-07 1999-08-05 Molecules designees b7l-1

Publications (1)

Publication Number Publication Date
IL140938A0 true IL140938A0 (en) 2002-02-10

Family

ID=22253041

Family Applications (3)

Application Number Title Priority Date Filing Date
IL14093899A IL140938A0 (en) 1998-08-07 1999-08-05 Molecules designated b7l-1
IL140938A IL140938A (en) 1998-08-07 2001-01-17 Dna sequences encoding polypeptides capable of binding to ldcam, polypeptides encoded by them, fusion proteins comprising the polypeptides and a process for the preparation of the polypeptides
IL196509A IL196509A (en) 1998-08-07 2009-01-14 Antibodies directed against polypeptides capable of binding to ldcam and pharmaceutical compositions comprising the same

Family Applications After (2)

Application Number Title Priority Date Filing Date
IL140938A IL140938A (en) 1998-08-07 2001-01-17 Dna sequences encoding polypeptides capable of binding to ldcam, polypeptides encoded by them, fusion proteins comprising the polypeptides and a process for the preparation of the polypeptides
IL196509A IL196509A (en) 1998-08-07 2009-01-14 Antibodies directed against polypeptides capable of binding to ldcam and pharmaceutical compositions comprising the same

Country Status (10)

Country Link
US (3) US6512095B2 (fr)
EP (1) EP1108042B1 (fr)
AT (1) ATE415480T1 (fr)
AU (1) AU771640B2 (fr)
CA (1) CA2337712A1 (fr)
DE (1) DE69939982D1 (fr)
ES (1) ES2315016T3 (fr)
IL (3) IL140938A0 (fr)
NZ (1) NZ510357A (fr)
WO (1) WO2000008057A2 (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030144478A1 (en) * 2001-02-06 2003-07-31 Immunex Corporation Molecules designated B7L-1
AU776825B2 (en) * 1998-08-07 2004-09-23 Immunex Corporation Molecules designated LDCAM
EP1108042B1 (fr) * 1998-08-07 2008-11-26 Immunex Corporation Molecules designees b7l-1
WO2000032633A1 (fr) * 1998-12-02 2000-06-08 Icos Corporation Nouvelle molecule d'adhesion et procedes d'utilisation
US7129338B1 (en) * 1999-07-08 2006-10-31 Research Association For Biotechnology Secretory protein or membrane protein
EP1514933A1 (fr) * 1999-07-08 2005-03-16 Research Association for Biotechnology Protéine sécrétoire ou protéine de membrane
AU8026500A (en) * 1999-10-18 2001-04-30 Texas Biotechnology Corporation Polynucleotides encoding human and murine adhesion proteins (bigr)
US6965018B2 (en) 2000-06-06 2005-11-15 Bristol-Myers Squibb Company Antibodies directed to B7-related polypeptide, BSL-2
MXPA02012718A (es) * 2000-06-28 2003-10-06 Amgen Inc Moleculas semejantes a b7 y sus usos.
CN1526011A (zh) * 2001-07-10 2004-09-01 IDECҩ�﹫˾ 抑制凋亡过程及改善细胞性能
JP2003116561A (ja) * 2001-10-11 2003-04-22 National Cancer Center-Japan Ｔｓｌｌ１遺伝子
EP1536821A4 (fr) * 2002-06-17 2009-09-09 Wyeth Corp Inhibition de l'activation de lymphocytes t par la butyrophiline a et la b7-l1
EP2133362B1 (fr) * 2003-07-25 2012-04-18 Amgen, Inc Procédés rélatifs aux LDCAM et CRTAM
DK2005185T3 (da) 2006-03-22 2011-01-31 Viral Logic Systems Technology Corp Fremgangsmåde til identifikation af polypeptidtargets
EP2069793B9 (fr) * 2006-08-29 2017-08-16 Oxford BioTherapeutics Ltd Identification d'une protéine associée à un carcinome hépatocellulaire, à un glioblastome et à un cancer du poumon
CN102341412B (zh) 2009-03-05 2018-01-05 梅达雷克斯有限责任公司 特异于cadm1 的全人抗体
UY35148A (es) 2012-11-21 2014-05-30 Amgen Inc Immunoglobulinas heterodiméricas
US9708375B2 (en) 2013-03-15 2017-07-18 Amgen Inc. Inhibitory polypeptides specific to WNT inhibitors
MX389325B (es) * 2013-07-30 2025-03-20 Fuller H B Co Pelicula adhesiva de poliuretano.
EP3041863A4 (fr) 2013-09-05 2017-08-16 Amgen Inc. Molécules contenant des fc et présentant des profils de glycoforme prévisibles, uniformes et reproductibles
US10156562B2 (en) 2014-05-16 2018-12-18 Amgen Inc. Assay for detecting Th1 and Th2 cell populations
CA3056011A1 (fr) 2017-03-14 2018-09-20 Amgen Inc. Controle des glycoformes afucosylees totales d'anticorps produits en culture cellulaire
US12325737B2 (en) 2018-03-26 2025-06-10 Amgen Inc. Total afucosylated glycoforms of antibodies produced in cell culture
BR112022005583A2 (pt) 2019-09-26 2022-09-20 Amgen Inc Métodos para a produção de composições de anticorpos
US20230273126A1 (en) 2020-06-04 2023-08-31 Amgen Inc. Assessment of cleaning procedures of a biotherapeutic manufacturing process
KR20230087539A (ko) 2020-10-15 2023-06-16 암젠 인크 항체 생산 방법에서의 상대적인 비결합 글리칸
EP4352094A1 (fr) 2021-06-07 2024-04-17 Amgen Inc. Utilisation de fucosidase pour contrôler le taux d'afucosylation de protéines glycosylées
US20250076309A1 (en) 2021-10-05 2025-03-06 Amgen Inc. Fc-gamma receptor ii binding and glycan content
WO2023215725A1 (fr) 2022-05-02 2023-11-09 Fred Hutchinson Cancer Center Compositions et méthodes pour l'immunothérapie cellulaire
AU2024256160A1 (en) 2023-04-20 2025-10-02 Amgen Inc. Methods of determining relative unpaired glycan content
WO2025038600A1 (fr) 2023-08-14 2025-02-20 Amgen Inc. Procédés de réduction de couleur jaune
WO2025101820A1 (fr) 2023-11-08 2025-05-15 Fred Hutchinson Cancer Center Compositions et méthodes pour l'immunothérapie cellulaire

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6218510B1 (en) 1994-03-02 2001-04-17 Brigham & Woman's Hospital B7-1 and B7-2 polypeptides
WO2000053753A2 (fr) 1999-03-08 2000-09-14 Genentech, Inc. Activation ou inhibition de l'angiogenese et de la cardiovascularisation
WO1998054963A2 (fr) 1997-06-06 1998-12-10 Human Genome Sciences, Inc. 207 proteines secretees humaines
AU6590898A (en) * 1997-03-28 1998-10-22 Genetics Institute Inc. Secreted proteins and polynucleotides encoding them
EP0970209A1 (fr) 1997-03-28 2000-01-12 Genetics Institute, Inc. Proteines secretees et polynucleotides les codant
NZ503343A (en) 1997-09-17 2002-09-27 Genentech Inc Secreted and transmembrane polypeptides and use to induce apoptosis of tumour cells
EP0939124A3 (fr) 1998-02-24 2001-03-21 Smithkline Beecham Plc Séquences de la MBGP1
EP1108042B1 (fr) * 1998-08-07 2008-11-26 Immunex Corporation Molecules designees b7l-1
WO2000032633A1 (fr) 1998-12-02 2000-06-08 Icos Corporation Nouvelle molecule d'adhesion et procedes d'utilisation
CN1242376A (zh) 1999-07-27 2000-01-26 中国医学科学院基础医学研究所 人神经系统特异表达基因

Also Published As

Publication number Publication date
AU5550499A (en) 2000-02-28
US7939640B2 (en) 2011-05-10
WO2000008057A3 (fr) 2000-05-18
NZ510357A (en) 2004-02-27
ATE415480T1 (de) 2008-12-15
CA2337712A1 (fr) 2000-02-17
WO2000008057A2 (fr) 2000-02-17
US6512095B2 (en) 2003-01-28
IL196509A (en) 2011-04-28
US20020164686A1 (en) 2002-11-07
US20100168399A1 (en) 2010-07-01
DE69939982D1 (de) 2009-01-08
EP1108042B1 (fr) 2008-11-26
IL140938A (en) 2010-12-30
IL196509A0 (en) 2009-09-22
AU771640B2 (en) 2004-04-01
US20080075724A1 (en) 2008-03-27
EP1108042A2 (fr) 2001-06-20
ES2315016T3 (es) 2009-03-16

Similar Documents

Publication Publication Date Title
NZ510357A (en) Molecules designated B7L-1
IL140937A0 (en) Molecules designated ldcam
DE69836088D1 (de) Als lerk6 bezeichnetes cytokin
IL193919A0 (en) DcR3 POLYPEPTIDE A TNFR HOMOLOG
AU3274995A (en) Fibrin-binding peptides, dna coding therefor and uses thereof
WO2000018914A3 (fr) NOUVEAUX POLYPEPTIDES $i(DKR)
EP0712862A3 (fr) Procédé d'acylation sélective des groupements d'amino-épsilon
AU3802595A (en) Tripeptidyl aminopeptidase
MX9702341A (es) Citoquina designada lerk-6.
EP0897011A3 (fr) Arginine deiminase
NZ294019A (en) Proteins associated with the hippocampus; dna sequences coding therefor, antibodies to the proteins
AU3118095A (en) Dna sequences coding for the human proteins tx and ty related to the interleukin-1beta converting enzyme
DE69939587D1 (en) Semaphorin polypeptide
AU1137699A (en) Novel reovirus-derived proteins, nucleic acids encoding same, and uses therefor
AU1183200A (en) Novel gene encoding brain-specific membrane protein
AU6844596A (en) Nucleotide sequence encoding the cd33-like protein
ZA99445B (en) Isolated, polypeptides which bind to HLA-A29 molecules nucleic acid, the molecules encoding these, and uses thereof.
SG74579A1 (en) Enzyme with leudh activity, nucleotide sequence coding therefor and process for the preparation of the enzyme
AU3667397A (en) Recombinant n-proteinase, and the production, methods and uses thereof
HK1031229A (en) Isolated, polypeptides which bind to hla-a29 molecules, nucleic acid, the molecules encoding these, and uses thereof
IE882662L (en) Dna sequences, recombinant dna molecules for producing¹soluble t4 proteins
HK1003061A (zh) 海马相关蛋白质，其dna序列编码及用途
AU2003200314A1 (en) Novel EGIII-like enzymes, DNA encoding such enzymes and methods for producing such enzymes